Cargando…
Drug Trafficking into Macrophages via the Endocytotic Receptor CD163
In inflammatory diseases, macrophages are a main producer of a range of cytokines regulating the inflammatory state. This also includes inflammation induced by tumor growth, which recruits so-called tumor-associated macrophages supporting tumor growth. Macrophages are therefore relevant targets for...
Autores principales: | Graversen, Jonas Heilskov, Moestrup, Søren Kragh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496642/ https://www.ncbi.nlm.nih.gov/pubmed/26111002 http://dx.doi.org/10.3390/membranes5020228 |
Ejemplares similares
-
Targeting of CD163(+) Macrophages in Inflammatory and Malignant Diseases
por: Skytthe, Maria K., et al.
Publicado: (2020) -
Specific targeting of CD163(+) TAMs mobilizes inflammatory monocytes and promotes T cell–mediated tumor regression
por: Etzerodt, Anders, et al.
Publicado: (2019) -
Anti-CD163-dexamethasone protects against apoptosis after ischemia/reperfusion injuries in the rat liver
por: Møller, Lin Nanna Okholm, et al.
Publicado: (2015) -
Targeting the Hemoglobin Scavenger receptor CD163 in Macrophages Highly Increases the Anti-inflammatory Potency of Dexamethasone
por: Graversen, Jonas H, et al.
Publicado: (2012) -
Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes
por: Svendsen, Pia, et al.
Publicado: (2016)